Yannick Plétan
59 works · 896 citations · h-index 15
Top works
- Milnacipran and selective serotonin reuptake inhibitors in major depression
- [Difficulties with conducting clinical trials in France].
- Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression
- A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients
- Rufloxacin Once Daily Versus Ciprofloxacin Twice Daily in the Treatment of Patients with Acute Uncomplicated Pyelonephritis
- Clinical efficacy of milnacipran
- La France est un pays attractif pour la recherche clinique internationale : enquête 2006 du Leem
- Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects
- Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab
- [Assessment of preventable iatrogenic drug therapy: methodology. Round Table No 2 at Giens XIII].
- Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
- Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode
- Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
- Comment améliorer les performances de la recherche clinique en France ?
- Place de la France dans la recherche clinique internationale : enquête 2010 du Leem France et recherche clinique internationale
- La France, un pays attractif pour la recherche clinique internationale : enquête 2008 du Leem
- Public-Private Partnership Models in France and in Europe
- Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
- Clinical Trials Legislation - Preparing for the Revision of the European Directive Scheduled for 2011
- Comité de Protection des Personnes